Top Markets
Coin of the day
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Classement en actions #25549
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Prix de l'action
$20.01
Dernière synchronisation: 2025-02-21
Capitalisation boursière
$48.36M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Singular Genomics Systems, Inc. (OMIC)

Catégorie

Revenus pour Singular Genomics Systems, Inc. (OMIC)
Revenus en Sep 2024 TTM : $2.67M
Selon les derniers rapports financiers de Singular Genomics Systems, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $2.67M. En 2022, l'entreprise a réalisé un chiffre d'affaires de $765.00K une augmentation par rapport à le chiffre d'affaires de l'année 2021, qui était de 0.00. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Singular Genomics Systems, Inc. de 2019 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $2.67M -8.42%
2023 $2.91M 280.52%
2022 $765.00K 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$11.03B 413,793.47%
US
$34.74B 1,302,846.52%
FR
- -
JP
$20.84B 781,557.91%
US
- -
CH